POAG must be redefined

POAG must be redefined
Howard Larkin
Howard Larkin
Published: Sunday, October 16, 2016
aao To better diagnose and treat patients, primary open-angle glaucoma (POAG) should be redefined in terms of several identifiable sub-types, Louis R Pasquale MD, of Harvard Medical School, Boston, USA, told Glaucoma subspecialty day at the 2016 AAO Annual Meeting in Chicago, USA. “PAOG is a remarkably heterogeneous disease with distinct but overlapping subtypes,” Dr Pasquale said in his American Glaucoma Society Lecture. Each has its own distinct age of onset, intraocular pressure (IOP) profile and structural optic nerve features, and biochemical markers point to specific biochemical pathways. Paracentral OAG, or PC OAG, in which vision loss is mainly in the paracentral region, is marked by low IOP and difficulty keeping IOP low enough to prevent progression, Dr Pasquale said. “16mm Hg is a high number for these patients.” PC OAG appears to be related to nitric oxide signalling, and patients should be encourage to eat foods with nitrates such as leafy green vegetables. Medications targeting NO are in development. African-derived OAG, or AD OAG, progresses quickly and appears in young patients, with one study of patients of African descent showing 20.9 per cent of those 20-40 years of age had IOPs of 24mm Hg or greater or cup to disc ratio of 0.7 or greater in one eye. It needs to be screened and treated early, and siblings and children of patients should be screened. Estrogen-derived OAG, or ED OAG, appears related to lower lifetime exposure to estrogen, with late menarche, oral contraceptive use, early menopause and early oophorectomy risk factors, Dr Pasquale said. Overall, high IOP is not a reliable marker for POAG with normal IOP observed in up to 90 per cent of glaucoma patients in some populations, Dr Pasquale noted. Pressures of 35 or higher are rare, and may indicate steroid exposure, physical pressure such as excessive eye rubbing, or secondary glaucoma. In cases of rapidly progressing glaucoma, diurnal curves should be taken and neuro-imaging considered. More study is needed to determine the subtypes and treatments for them, Dr Pasquale concluded. “Let’s help our patients by taking the ‘P’ out of PAOG.”  
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...